Metraipolis › archive › dc_b20bb419f278
The Role of Immune Checkpoint Inhibitors in Cancer Therapy: Mechanism and Therapeutic Advances — Europe PMC PMID:41059489
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41059489
- DOI
- 10.1002/mco2.70412
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:55:30.707Z
- SHA-256 of the archived text
d2e3b7f9a3efad751be9e480ca8d9695a00a73714496dcd8ac3cf65d326e4f4e- Stable URL of this page
https://metraipolis.com/documento/dc_b20bb419f278
How to cite
The Role of Immune Checkpoint Inhibitors in Cancer Therapy: Mechanism and Therapeutic Advances — Europe PMC PMID:41059489 — Europe PMC (en), https://europepmc.org/article/MED/41059489 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b20bb419f278 (Metraipolis archive dc_b20bb419f278, sha256 d2e3b7f9a3efad751be9e480ca8d9695a00a73714496dcd8ac3cf65d326e4f4e)
BibTeX
@misc{dcb20bb419f278,
title = {The Role of Immune Checkpoint Inhibitors in Cancer Therapy: Mechanism and Therapeutic Advances — Europe PMC PMID:41059489},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41059489},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b20bb419f278; sha256 d2e3b7f9a3efad751be9e480ca8d9695a00a73714496dcd8ac3cf65d326e4f4e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41059489. Agents can read the archived copy with the MCP tool read_document.